It has been demonstrated previously that molecular decoys of the acety
lcholine receptor have therapeutic efficacy as antitoxins [Gershoni,J.
and Aronheim,A. (1988) Proc. Natl Acad. Sci. USA, 85, 4087-4089], but
surely a most challenging goal is to apply this approach towards the
development of antiviral drugs. As viruses present multiple copies of
their envelope proteins, it was proposed that polyvalent decoys could
be advantageous. Here we report the design and expression of recombina
nt linear polymers of the HIV gp120-binding domains which are situated
within the T-cell membrane protein CD4. Whereas the production of lin
ear concatemers of CD4 variable domains is feasible, a number of confo
rmational constraints must be considered when designing a polymeric mo
lecule which retains biological function. Most significant is the cont
ribution of domains flanking the binding site that apparently enable c
orrect folding of the latter.